The Epilepsy Foundation's 4th Biennial Epilepsy Pipeline Update Conference.
On June 5 and 6, 2014, the Epilepsy Foundation held its 4th Biennial Epilepsy Pipeline Update Conference, an initiative of the Epilepsy Therapy Project, which showcased the most promising epilepsy innovations from health-care companies and academic laboratories dedicated to pioneering and advancing drugs, biologics, technologies, devices, and diagnostics for epilepsy. Speakers and attendees included emerging biotech and medical technology companies, major pharmaceutical and device companies, as well as investigators and innovators at the cutting-edge of epilepsy. The program included panel discussions on collaboration between small and large companies, how to get products in need of funding to the marketplace, who is currently funding epilepsy and CNS innovation, and how the NIH facilitates early-stage drug development. Finally, the conference featured the third annual "Shark Tank" competition. The presentations are summarized in this paper, which is followed by a compilation of the meeting poster abstracts.
Department of Neurology, New York University Langone Medical Center, New York, NY, USA.
Jacqueline A
JA
French
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Neurology, Harvard Medical School, Boston, MA, USA; Consortia for Improving Medicine Through Innovation and Technology, Boston, MA, USA. Electronic address: sschacht@bidmc.harvard.edu.
Steven C
SC
Schachter
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA.
Joseph
J
Sirven
Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA; Department of Pharmacology, USUHS, Bethesda, MD, USA.
Roger
R
Porter
D003226:Congresses as Topic; D055808:Drug Discovery; D004827:Epilepsy / Q000175:diagnosis* / Q000188:drug therapy*; D004864:Equipment and Supplies; D006801:Humans
Devices; Diagnostics; Epilepsy; Food and Drug Administration; Innovation; Pipeline; Seizure; Therapies